Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chester V Oddis

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
Rheumatology (Oxford, England)|January 5, 2019
Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinibSiamak Moghadam-Kia, Devon Charlton, Rohit Aggarwal, et al.
Rheumatic Diseases Clinics of North America|July 8, 2020
Risk Factors and Cancer Screening in MyositisSiamak Moghadam-Kia, Chester V Oddis, Dana P Ascherman, et al.
The Journal of Rheumatology|October 17, 2009
Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa proteinGraciela Espada, Jose A Maldonado Cocco, Noreen Fertig, et al.
Arthritis and Rheumatism|April 1, 2009
Anti-U3 RNP autoantibodies in systemic sclerosisRohit Aggarwal, Mary Lucas, Noreen Fertig, et al.
The Journal of Rheumatology|January 17, 2017
Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with DermatomyositisSiamak Moghadam-Kia, Chester V Oddis, Shinji Sato, et al.
Critical Care (London, England)|September 13, 2012
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspectivePashtoon M Kasi, Hussein A Tawbi, Chester V Oddis, et al.
Arthritis and Rheumatism|January 20, 2004
Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathyAmy H Kao, David Lacomis, Mary Lucas, et al.
Arthritis Care & Research|September 29, 2015
Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic DermatomyositisSiamak Moghadam-Kia, Chester V Oddis, Shinji Sato, et al.
Chest|December 9, 2010
Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?Geoffrey R Connors, Lisa Christopher-Stine, Chester V Oddis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositisDana P Ascherman, Timothy B Oriss, Chester V Oddis, et al.
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Rheumatology (Oxford, England)|January 5, 2019
Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinibSiamak Moghadam-Kia, Devon Charlton, Rohit Aggarwal, et al.
Rheumatic Diseases Clinics of North America|July 8, 2020
Risk Factors and Cancer Screening in MyositisSiamak Moghadam-Kia, Chester V Oddis, Dana P Ascherman, et al.
The Journal of Rheumatology|October 17, 2009
Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa proteinGraciela Espada, Jose A Maldonado Cocco, Noreen Fertig, et al.
Arthritis and Rheumatism|April 1, 2009
Anti-U3 RNP autoantibodies in systemic sclerosisRohit Aggarwal, Mary Lucas, Noreen Fertig, et al.
The Journal of Rheumatology|January 17, 2017
Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with DermatomyositisSiamak Moghadam-Kia, Chester V Oddis, Shinji Sato, et al.
Critical Care (London, England)|September 13, 2012
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspectivePashtoon M Kasi, Hussein A Tawbi, Chester V Oddis, et al.
Arthritis and Rheumatism|January 20, 2004
Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathyAmy H Kao, David Lacomis, Mary Lucas, et al.
Arthritis Care & Research|September 29, 2015
Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic DermatomyositisSiamak Moghadam-Kia, Chester V Oddis, Shinji Sato, et al.
Chest|December 9, 2010
Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?Geoffrey R Connors, Lisa Christopher-Stine, Chester V Oddis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositisDana P Ascherman, Timothy B Oriss, Chester V Oddis, et al.
Pageof 17